Management of Asymptomatic Ovarian and Other Adnexal Cysts Imaged at US: Society of Radiologists in Ultrasound Consensus Conference Statement1 — Radiology

Note: excellent detailed paper

How to follow up advanced-stage borderline tumours? Mode of diagnosis of recurrence in a large series stage II-III serous borderline tumours of the ov

BACKGROUND: The aim of this study was to describe how recurrences were diagnosed in the largest series of patients treated for an advanced-stage serous borderline ovarian tumour.
PATIENTS AND METHODS: From 1973 to 2006, 45 patients with a serous borderline tumour and peritoneal implants relapsed among 162 patients with a follow-up exceeding 1 year. Data concerning recurrences and the mode of diagnosis were reviewed.
CONCLUSIONS: This study demonstrates that ultrasound is the most relevant follow-up procedure in this context. Nevertheless, the blood CA 125 test is of particular interest for detecting invasive recurrent disease, which is the most crucial event.

Epithelial Ovarian Cancer Clinical Trial: A Trial Using Novel Markers to Predict Malignancy in Elevated-Risk Women [Conditions: Epithelial Ovarian Cancer; Interventions

Epithelial Ovarian Cancer Clinical Trial:

Brief Summary

Official Title: “A Randomized Controlled Trial Using Novel Markers to Predict Malignancy in Elevated-Risk Women”

Condition Keyword(s):

• Epithelial Ovarian Cancer

Intervention(s):

• Procedure: CA125 assay on Abbott Architect i1000SR platform
• Procedure: HE4 assay on Architect i1000SR platform
• Procedure: Transvaginal Ultrasound

The Novel Markers Trial will compare the safety, feasibility and effectiveness of two different epithelial ovarian cancer screening strategies that use CA125 and add HE4 as either a first or second line screen. This study is the next step in a larger research effort to develop a blood test that can be used as a screening method for the early detection of epithelial ovarian cancer.

Survivin Small Interfering RNA Transfected With a Microbubbl... : International Journal of Gynecological Cancer

Conclusions: Delivery of survivin siRNA using a microbubble contrast agent combined with ultrasound exposure can effectively inhibit survivin expression and induce apoptosis, providing a new promising approach for siRNA delivery in vivo.

News - Transvaginal Ultrasound May Reduce Ovarian Tumour Surgeries: Presented at SGO

Reference Source: Presentation title: Risk of Malignancy in Sonographically Confirmed Septated Cystic Ovarian Tumors. Abstract 53